Karyomapping in Preimplantation Genetic Testing of Patients with Beta-thalassemia and Sickle Cell Anemia
Abstract
Aim
Preimplantation genetic testing (PGT) has been introduced to prevent the transmission of inherited diseases to the offspring. Karyomapping is a universal linkage-based test that has been recently introduced to PGT in the clinical practice. It utilizes single nucleotide polymorphism genotyping of individual parents along with a known disease reference from a family member for identification of the parental origin of chromosomes and the disease status of the embryos being tested. The objectives of this study were to first validate Karyomapping technique on previously known beta globin (HBB) test sample results and then establish as a sole PGT method for HBB mutation identification in the future.
Materials and Methods
First, Karyomapping protocol was validated on a total of 30 samples with HBB mutation identified by conventional PGT techniques. Then, Karyomapping was used on 31 samples as the sole technique to identify HBB mutation status.
Results
We found a high concordance (97%) between the Karyomapping and conventional PGT results. For five PGT cycles for HBB mutations and direct Karyomapping PGT four unaffected and chromosomal normal embryos were transferred resulting two pregnancies.
Conclusion:Karyomapping technique can reliably detect HBB mutation in clinical cases without a prior test development in the clinical practice and prevents the transfer of aneuploidy embryos.
Keywords
References
- Reference 1. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 199;344(6268):768-70.
- Reference 2. Handyside AH, Lesko JG, Tarin JJ 1992 Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med. 1992;327(13):905-9.
- Reference 3. Sermon K. Novel technologies emerging for preimplantation genetic diagnosis and preimplantation genetic testing for aneuploidy. Expert Rev Mol Diagn. 2017;17(1):71-82.
- Reference 4. Verlinsky Y, Rechitsky S, Schoolcraft W et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA. 2001;285(24):3130-3.
- Reference 5. Hellani A, Coskun S, Benkhalifa M 2004 Multiple displacement amplification on single cell and possible PGD applications. Mol Hum Reprod. 2004;10(11):847-52.
- Reference 6. Coskun S, Alsmadi O. Whole genome amplification from a single cell: a new era for preimplantation genetic diagnosis. Prenat Diagn. 2007;27(4):297-302.
- Reference 7. Findlay I, Ray P, Quirke P, Rutherford A, Lilford R. Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation diagnosis of sex and cystic fibrosis. Hum Reprod. 1995;10(6):1609-18.
- Reference 8. Findlay I, Matthews PL, Mulcahy BK, Mitchelson K. Using MF-PCR to diagnose multiple defects from single cells: implications for PGD. Mol Cell Endocrinol. 2001;183(Suppl 1):S5-12.
- Reference 9. Hellani A, Coskun S, Tbakhi A, Al-Hassan S. Clinical application of multiple displacement amplification in preimplantation genetic diagnosis. Reprod Biomed Online. 2005;10(3):376-80.
- Reference 10. Handyside AH, Robinson MD, Simpson RJ, Omar MB, Shaw MA, Grudzinskas JG, Rutherford A. Isothermal whole genome amplification from single and small numbers of cells: a new era for preimplantation genetic diagnosis of inherited disease. Mol Hum Reprod. 2004;10(10):767-72.